Recent reviews for our training courses include:

“Thoroughly enjoyable with tremendous speakers who took us through an exponential learning curve!” Product Representative, Merck Sharp & Dohme, UK

“An excellent course which refreshed and up-dated my knowledge of cardiovascular drugs. The tutors enthusiastically provided an extensive review of current therapies which was supported by data from clinical studies. I would definitely recommend the course to anyone with an interest in cardiovascular disease.” Senior Scientist in Safety Pharmacology, Pfizer Limited, UK

“I thoroughly enjoyed the course and found it to be very useful. It provided me with a very insightful understanding into the world of COPD. All speakers were very good at providing an in-depth knowledge into the disease area and sharing their particular expertise. I would certainly recommend it to other colleagues.” Regulatory Project Manager, GlaxoSmithKline, UK

“Overall, the course was excellent, well-balanced and informative. It was useful having a small group which made it more personal and allowed some good Q&A and debate. The sessions were well designed in terms of providing information on prevalence, pathophysiology, diagnosis, clinical and drug treatment for IBS, acid-related diseases and IBD. The speakers were excellent. I would certainly recommend the courses to colleagues, particularly those new to the organisation and/or a particular therapeutic area. A useful and successful course for me”. Associate Director of Clinical Science, Takeda, UK